{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:38:00Z","timestamp":1792730280949,"version":"4.5.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Key Research and Development Program of China","award":["2022YFC2304400 and 2022YFC2304401"],"award-info":[{"award-number":["2022YFC2304400 and 2022YFC2304401"]}]},{"name":"the National Key Research and Development Program of China","award":["2022YFC2304400 and 2022YFC2304401"],"award-info":[{"award-number":["2022YFC2304400 and 2022YFC2304401"]}]},{"name":"the National Key Research and Development Program of China","award":["2022YFC2304400 and 2022YFC2304401"],"award-info":[{"award-number":["2022YFC2304400 and 2022YFC2304401"]}]},{"name":"the National Key Research and Development Program of China","award":["2022YFC2304400 and 2022YFC2304401"],"award-info":[{"award-number":["2022YFC2304400 and 2022YFC2304401"]}]},{"name":"the National Key Research and Development Program of China","award":["2022YFC2304400 and 2022YFC2304401"],"award-info":[{"award-number":["2022YFC2304400 and 2022YFC2304401"]}]},{"name":"the National Key Research and Development Program of China","award":["2022YFC2304400 and 2022YFC2304401"],"award-info":[{"award-number":["2022YFC2304400 and 2022YFC2304401"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05105-2","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:54:52Z","timestamp":1785138892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Precise immunomodulation by mesenchymal stem cells mitigates hepatitis B virus-specific CD8\u207a T cell-mediated acute liver injury without compromising viral clearance"],"prefix":"10.1186","volume":"17","author":[{"given":"Xingxing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"5105_CR1","doi-asserted-by":"publisher","first-page":"2500490","DOI":"10.1080\/21505594.2025.2500490","volume":"16","author":"H Guo","year":"2025","unstructured":"Guo H, Fang F, Lin L, Guo Z, Lai L, Shi Y, et al. Novel prognostic scoring models for hepatitis B virus-related acute-on-chronic liver failure: A comparison with classical models. Virulence. 2025;16:2500490.","journal-title":"Virulence"},{"key":"5105_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:353\u201390.","journal-title":"Hepatol Int"},{"key":"5105_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S2468-1253(23)00363-1","volume":"9","author":"F Artru","year":"2024","unstructured":"Artru F, Trovato F, Morrison M, Bernal W, McPhail M. Liver transplantation for acute-on-chronic liver failure. Lancet Gastroenterol Hepatol. 2024;9:564\u201376.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"5105_CR4","doi-asserted-by":"publisher","first-page":"6922","DOI":"10.3748\/wjg.v28.i48.6922","volume":"28","author":"B Della Guardia","year":"2022","unstructured":"Della Guardia B, Boteon APCS, Matielo CEL, Felga G, Boteon YL. Current and future perspectives on acute-on-chronic liver failure: Challenges of transplantation, machine perfusion, and beyond. World J Gastroenterol. 2022;28:6922\u201334.","journal-title":"World J Gastroenterol"},{"key":"5105_CR5","doi-asserted-by":"publisher","first-page":"834","DOI":"10.2174\/1574888X18666221214123844","volume":"18","author":"F Cheng","year":"2023","unstructured":"Cheng F, Huang Z, Wei W, Li Z. Mesenchymal stem cell transplantation for hepatitis B virus-related acute-on-chronic liver failure: A systematic review and meta-analysis. Curr Stem Cell Res Ther. 2023;18:834\u201342.","journal-title":"Curr Stem Cell Res Ther"},{"key":"5105_CR6","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.3389\/fimmu.2019.02240","volume":"10","author":"K Heim","year":"2019","unstructured":"Heim K, Neumann-Haefelin C, Thimme R, Hofmann M. Heterogeneity of HBV-specific CD8\u2009+\u2009T-cell failure: implications for immunotherapy. Front Immunol. 2019;10:2240.","journal-title":"Front Immunol"},{"key":"5105_CR7","doi-asserted-by":"publisher","first-page":"893","DOI":"10.7150\/ijbs.39725","volume":"16","author":"C Hu","year":"2020","unstructured":"Hu C, Wu Z, Li L. Mesenchymal stromal cells promote liver regeneration through regulation of immune cells. Int J Biol Sci. 2020;16:893\u2013903.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"5105_CR8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13287-022-02825-z","volume":"13","author":"S Shokravi","year":"2022","unstructured":"Shokravi S, Borisov V, Zaman BA, Niazvand F, Hazrati R, Khah MM, Thangavelu L, Marzban S, Sohrabi A, Zamani A. Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review. Stem Cell Res Ther. 2022;13(1):192.","journal-title":"Stem Cell Res Ther"},{"key":"5105_CR9","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s12072-021-10199-2","volume":"15","author":"M Shi","year":"2021","unstructured":"Shi M, Li YY, Xu RN, Meng FP, Yu SJ, Fu JL, et al. Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial. Hepatol Int. 2021;15:1431\u201341.","journal-title":"Hepatol Int"},{"issue":"9","key":"5105_CR10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song N, Scholtemeijer M, Shah K. Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential. Trends Pharmacol Sci. 2020;41(9):653\u201364.","journal-title":"Trends Pharmacol Sci"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05105-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05105-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05105-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:58:54Z","timestamp":1792727934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05105-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5105"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05105-2","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MenSCs and UC-MSCs were obtained from Zhejiang Shengchuang Precision Medicine Technology Co., Ltd (title: \u201cA Clinical Study on the Safety and Preliminary Efficacy of Menstrual Blood-Derived Mesenchymal Stem Cells in the Treatment of Mild to Moderate Alzheimer\u2019s Disease\u201d; approval number Stem Cell Therapy Documentary Review No. 1GS [2019]; granted September 5, 2019. Human liver tissues were obtained from Southern University of Science and Technology Hospital (SUSTech Hospital; title: \u201cResearch on Clinical Treatment Strategies for Major Infectious Diseases Based on Stem Cell Technology\u201d; approval number 2022YXY133; granted June 21, 2022) and Shenzhen Third People\u2019s Hospital (title: \u201cResearch on Clinical Treatment Strategies for Major Infectious Diseases Based on Stem Cell Technology\u201d; approval number HE2022256; granted June 20, 2022). Peripheral blood mononuclear cells (PBMCs) were obtained from donors at Shenzhen People\u2019s Hospital (title: \u201cMechanisms of Gut Microenvironmental Impact on Respiratory Infections and Treatment\u201d; approval number LL-KY-2024170-01; granted October 19, 2024). Plasma samples from healthy donors and patients with HBV-related acute-on-chronic liver failure (HBV-ACLF) were obtained from the Fifth Medical Center of the Chinese PLA General Hospital (title: \u201cClinical Study on Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Acute-on-Chronic Liver Failure\u201d; approval number KY-2023-3-19-1; granted April 6, 2023). All participants or their legally authorized representatives provided written informed consent for participation in the study and for the use of their samples.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"380"}}